アステラス製薬さんのカバー写真
アステラス製薬

アステラス製薬

医薬品製造業

Chuo-Ku、Tokyo657,005人のフォロワー

アステラス製薬は、科学の進歩を患者さんの「価値」に変えることにコミットしています。

概要

アステラス製薬は、科学の進歩を患者さんの「価値」に変えることを目指すグローバルライフサイエンス企業です。私たちは、がんや、眼科・泌尿器疾患、免疫、ウィメンズヘルスなどの多様な領域において、革新的な治療法を提供しています。研究開発プログラムを通じて、アンメットメディカルニーズの高い疾患領域において新たなヘルスケアソリューションを開拓しています。 このページ内でのコミュニケーションについては「アステラスグローバルLinkedInコミュニティガイドライン」をご覧ください。 https://www.astellas.com/jp/global-linkedin-community-guidelines

ウェブサイト
http://www.astellas.com/
業種
医薬品製造業
会社規模
社員 10,001名以上
本社
Chuo-Ku、Tokyo
種類
上場企業
専門分野
Pharmaceuticals、医薬品

場所

アステラス製薬の社員

アップデート

  • As we mark Geographic Atrophy (GA) Awareness Week, we are celebrating the many perspectives that remind us why sight matters. GA is an advanced and irreversible form of age-related macular degeneration that causes progressive vision loss. It is estimated to affect approximately 5 million people around the world. Earlier this year, on World Sight Day, we launched our internal #TheBestThingsInLifeAreSeen2025 competition to highlight the moments our colleagues treasure and how our eyes help us take in the richness of life and the experiences that matter most. With entries received from around the world, we were grateful to partner with the International Agency for the Prevention of Blindness (IAPB), who supported the judging and helped us select this year’s winner and runners up. Their reflections capture the power of vision and the importance of our shared commitment to those living with GA. ●The Milky Way, as seen from a state park, Indiana, U.S. – Matt I’ve worn glasses my entire life and I remember how scary it was to realize I couldn’t see the front of the room in school as a young boy. I’m a Boy Scout leader and tell my Scouts all the time to get their eyes up (and off their phones!). Our trips take us away from the city lights – and on a good, clear night we can be rewarded with shooting stars, satellites, or even the Milky Way, pictured here. I hope that this inspires others to pause, eyes up, and look for the things we don’t typically get to see.  ●Red-crowned cranes at Zhalong National Nature Reserve, China – Lingyan  Eyes are among the most vital avenues through which we attain direct experience. In August this year I made my travel visit to Zhalong National Nature Reserve in China, the world’s largest sanctuary for red-crowned cranes. As depicted in the picture, the harmonious beauty of the red-crowned cranes and the natural landscape there ... left an indelible impression. We ought to treasure our eyes and protect eye vision, just as we value our health and time. ●Train through the Jungfraujoch, the highest railway in Europe - Carly I feel so much joy in all that I get to experience with my eyes. I am sharing this particular photo because it represents me taking it all in. In this photo I am looking out a train through the Jungfraujoch – the highest railway in Europe. There is so much beauty in this world, both big and small. I am guilty of taking my ability to see it for granted, but this World Sight Day reminded me just how lucky I am. Thank you to everyone who took part and shared the moments that inspire the work we do every day.

  • One Week Left to Submit Your Applications for the Pitch Event for Investor Day Japan.  Calling life science innovators and entrepreneurs. We’re excited to announce that on March 19 Astellas, BioLabs Global (U.S.), the Innovation Center of Nanomedicine (iCONM) in collaboration with BioLabs and Life Science Innovation Network Japan (LINK-J) will co-host #InvestorDayJapan2026.     The Investor Day Japan 2026 pitch event will bring together the BioLabs community in Japan with the global BioLabs network to provide a platform for early- to mid-stage drug discovery startups to share their stories with investors and industry experts, providing participating entrepreneurs with the opportunity to network with their peers, seize new business opportunities and accelerate the growth of their drug discovery ventures.    We welcome submissions from around the globe – you do not need to be based in Japan to take part. We are accepting pitch applications through December 5. Visit the event website to learn more about eligibility criteria, the pitch submission process and how to attend the pitch event in person.  https://lnkd.in/gDMXFexa #StartupPitch #PioneeringScience

  • For millions of families, a rare disease diagnosis often marks the start of a lifelong journey of caregiving – one filled with uncertainty, complex care needs and emotional strain. Parents, siblings and sometimes grandparents take on critical roles managing treatment plans, navigating specialists and making life-shaping decisions, all while juggling other responsibilities. This #NationalFamilyCaregiversMonth, we’re shining a light on the central role that caregivers play, particularly those caring for people with rare diseases. To every caregiver around the world, thank you. This month, and every month, your work deserves recognition, respect and support. #ChangingTomorrow #AstellasPioneeringScience

    • この画像には代替テキストの説明がありません
  • Astellas Chief Financial Officer Atsushi Kitamura was a recent guest on the CFO THOUGHT LEADER podcast where he shared insights about his career across diverse industries and discussed his financial playbook for Astellas.     Listen to the full episode: https://lnkd.in/gqmufzjJ   #CFOThoughtLeader #innovation #CFOLeadership #ChangingTomorrow 

  • Launched in April 2025, the Astellas Innovation Lab is redefining how we collaborate to accelerate breakthrough science. Led by Morten Sogaard, we are uniting our research efforts and bringing a fresh approach to external R&D, focused on high-impact indications and cutting-edge platforms for validated targets.  In his recent conversation with #InVivo Citeline, Morten shares how we are balancing innovation and risk through tailored partnerships, while building ecosystems that nurture growth and enable true co-creation through Astellas’ #SakuLab in Tsukuba, Japan and Cambridge, MA.     From disciplined due diligence to purposeful use of AI, our Innovation Lab is positioning Astellas, and its partners, for the next wave of transformative medicines.    Read Morten’s feature interview here (subscription required): bit.ly/4nBZW7j #ChangingTomorrow #AstellasPioneeringScience 

    • この画像には代替テキストの説明がありません
  • At Astellas, science isn’t just what we do – it’s how we change tomorrow. On UNESCO ’s #WorldScienceDay for Peace and Development, we celebrate bold ideas and breakthrough scientific innovation to create sustainable solutions for global challenges. We’re not chasing the expected – we’re pioneering what’s never been done before. By focusing on breakthrough areas of R&D, partnering with ambitious innovators and building future-ready capabilities, we’re accelerating the delivery of transformative medicines for patients worldwide. Watch our video to see how Astellas is pioneering science – transforming hope into real impact for patients everywhere. Let’s shape the future, together. #ChangingTomorrow #AstellasPioneeringScience

  • アステラス製薬の組織ページを表示

    657,005人のフォロワー

    Integrity is more than a principle at Astellas - it’s a skill we strengthen every day. Earlier this year, our Ethics & Compliance and HR teams launched “Building an Ethical Culture,” a new highly interactive workshop designed to bring ethical leadership to life in practical and meaningful ways. Over 1,500 senior leaders and managers from across the globe have participated in these cross-functional sessions, which is a powerful sign of our shared commitment to championing Integrity across Astellas. The feedback has been inspiring with 100% of participants said they better understand the critical role leaders play in modelling Integrity, and 90% feel more confident communicating to build trust, respect and transparency. At Astellas, Integrity isn’t just a word on a page —it’s a lived value that shapes our decisions, our teams and our interactions every day. It’s no surprise that Integrity consistently ranks as one of our greatest strengths in the annual Global Engagement Survey. These workshops are designed to keep that momentum alive—ensuring Integrity remains not only top of mind, but deeply embedded in how we lead, collaborate and make an Impact. We’re excited to see how these learnings continue to cascade across the organization as we continue to grow our ethical culture - together.

    • この画像には代替テキストの説明がありません
  • アステラス製薬の組織ページを表示

    657,005人のフォロワー

    We are proud to announce that Astellas has been awarded the prestigious “White 500” accreditation by Japan’s Ministry of Economy, Trade and Industry. This recognition reflects our four-year commitment to enhancing employee well-being, health and safety, and fostering both individual health and a sound corporate culture. As human capital management continues to gain importance amid evolving work styles and demographic changes, we strive to advance our vision every day. We believe that investing in employee health is essential for sustainable growth. Our approach to Certified KENKO Investment for Health (KIH)* embodies this belief—viewing well-being not as a cost, but as a strategic investment in our people and our future. Through KIH, we aim to strengthen employee engagement, boost productivity, and enhance organizational vitality. This aligns with our mission to continuously deliver VALUE to our patients and stakeholders through a thriving, empowered workforce. We are honored by this recognition and remain committed to advancing health investment practices that benefit both individuals and society as a whole. See Astellas’ initiatives for KENKO Investment for Health on our corporate website: https://bit.ly/47WQV4a * KENKO Investment for Health (KIH) is a management strategy that prioritizes employee health and connects it to corporate growth and profitability. Learn more about KIH here: https://kenko-keiei.jp/en/ #EmployeeWellbeing #HealthInvestment #SustainableGrowth

    • この画像には代替テキストの説明がありません
  • Every day, the choices we make shape who we are as a company. At Astellas, those choices are guided by our Organizational Values & Behaviors and reinforced by our reimagined Code of Conduct. Our global Code has been redesigned to be clearer, more practical, and more accessible. It helps us navigate complex ethical situations with even greater confidence and consistency. More than 100 employees across Astellas contributed to this update, ensuring it reflects our lived reality - not just policies on a page. Whether we’re making decisions under pressure, collaborating across borders, or speaking up when something doesn’t feel right, the Code is there to guide us. It builds trust, enables innovation, and drives impact for patients. Integrity remains at the heart of our culture - a strength consistently recognized in our Global Engagement Survey and lived daily by colleagues around the world. It’s not just one of our Astellas Values - it’s the first, and that’s intentional. Our Code of Conduct is rooted in this principle because Integrity is the compass that guides everything we do. From major business decisions to everyday choices, Integrity keeps us aligned to our purpose. And when we lead with Integrity, we amplify our ability to Innovate and deliver Impact that drives VALUE for patients globally. That’s what inspires us, cultivates trust, and makes us proud.

    • この画像には代替テキストの説明がありません
  • The thriving life sciences community in Greater Boston continues to set the pace for global innovation – even as new biotech hubs emerge worldwide. At a recent STAT Brand Studio Open Doors event, hosted at our Cambridge-based Astellas Life Sciences Center, leaders from across the industry came together to discuss how Boston’s unique mix of talent, infrastructure and collaborative spirit keeps it at the forefront of biopharma. The conversation explored how open innovation and partnerships – locally and globally – are essential to tackling today’s toughest healthcare challenges. Astellas is proud to invest in the Boston area to help drive the next wave of scientific breakthroughs, working alongside partners who share our vision for a healthier future.    Read the full STAT article for insights from the event: https://lnkd.in/gPXNFc5q   #BostonInnovation #ChangingTomorrow #AstellasPioneeringScience 

類似するページ

資金調達

アステラス製薬 合計1ラウンド

最終ラウンド

付与

投資家およびグループ

National Institute on Drug Abuse (NIDA)
Crunchbaseで詳しい情報を表示